159 related articles for article (PubMed ID: 8931985)
1. Effect of lanreotide on local kidney IGF-I and renal growth in experimental diabetes in the rat.
Grønbaek H; Nielsen B; Frystyk J; Flyvbjerg A; Orskov H
Exp Nephrol; 1996; 4(5):295-303. PubMed ID: 8931985
[TBL] [Abstract][Full Text] [Related]
2. Effect of octreotide on experimental diabetic renal and glomerular growth: importance of early intervention.
Grønbaek H; Nielsen B; Frystyk J; Orskov H; Flyvbjerg A
J Endocrinol; 1995 Oct; 147(1):95-102. PubMed ID: 7490542
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effects of octreotide on renal and glomerular growth in early experimental diabetes in mice.
Grønbaek H; Nielsen B; Schrijvers B; Vogel I; Rasch R; Flyvbjerg A
J Endocrinol; 2002 Mar; 172(3):637-43. PubMed ID: 11874712
[TBL] [Abstract][Full Text] [Related]
4. IGF-1 and acute renal hypertrophy: inhibition by somatostatin analogues.
Orskov H; Flyvbjerg A; Frystyk J; Grønbaek H; Foegh M; Harris AG
Transplant Proc; 1993 Apr; 25(2):2061-2. PubMed ID: 8097067
[No Abstract] [Full Text] [Related]
5. Regional changes in the intrarenal insulin-like growth factor-I axis in diabetes.
Fervenza FC; Tsao T; Hoffman AR; Rabkin R
Kidney Int; 1997 Mar; 51(3):811-8. PubMed ID: 9067915
[TBL] [Abstract][Full Text] [Related]
6. Kidney IGF-I and renal hypertrophy in GH-deficient diabetic dwarf rats.
Flyvbjerg A; Frystyk J; Osterby R; Orskov H
Am J Physiol; 1992 Jun; 262(6 Pt 1):E956-62. PubMed ID: 1616029
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of a growth hormone receptor antagonist (G120K-PEG) on renal enlargement, glomerular hypertrophy, and urinary albumin excretion in experimental diabetes in mice.
Flyvbjerg A; Bennett WF; Rasch R; Kopchick JJ; Scarlett JA
Diabetes; 1999 Feb; 48(2):377-82. PubMed ID: 10334317
[TBL] [Abstract][Full Text] [Related]
8. Octreotide prevents the early increase in renal insulin-like growth factor binding protein 1 in streptozotocin diabetic rats.
Raz I; Rubinger D; Popovtzer M; Grønbaek H; Weiss O; Flyvbjerg A
Diabetes; 1998 Jun; 47(6):924-30. PubMed ID: 9604870
[TBL] [Abstract][Full Text] [Related]
9. Effect of octreotide and insulin on manifest renal and glomerular hypertrophy and urinary albumin excretion in long-term experimental diabetes in rats.
Grønbaek H; Nielsen B; Osterby R; Harris A; Orskov H; Flyvbjerg A
Diabetologia; 1995 Feb; 38(2):135-44. PubMed ID: 7536170
[TBL] [Abstract][Full Text] [Related]
10. Differential distribution of insulin-like growth factor-1 and insulin-like growth factor binding proteins in experimental diabetic rat kidney.
Miyatake N; Shikata K; Wada J; Sugimoto H; Takahashi S; Makino H
Nephron; 1999; 81(3):317-23. PubMed ID: 10050087
[TBL] [Abstract][Full Text] [Related]
11. Renal enlargement and insulin-like growth factor-1 accumulation in the Wistar rat model of experimental diabetes is not prevented by angiotensin converting enzyme inhibition.
New JP; Canavan JP; Flyvbjerg A; Hamon G; Bilous RW; Marshall SM
Diabetologia; 1996 Feb; 39(2):166-71. PubMed ID: 8635668
[TBL] [Abstract][Full Text] [Related]
12. Pre- and post-translational regulation of renal insulin-like growth factor binding protein-1 in insulin-deficient diabetes.
Kaufman CR; Catanese VM
J Investig Med; 1995 Apr; 43(2):178-86. PubMed ID: 7537614
[TBL] [Abstract][Full Text] [Related]
13. Loss of kidney IGF-1 receptors in experimental long-term diabetic rats.
Obineche EN; Mensah-Brown E; Chandranath SI; Arafar K; Adem A
Endocr Res; 2001 Aug; 27(3):293-302. PubMed ID: 11678576
[TBL] [Abstract][Full Text] [Related]
14. Expression of insulin-like growth factor binding proteins in the rat kidney: effects of long-term diabetes.
Landau D; Chin E; Bondy C; Domene H; Roberts CT; Gronbaek H; Flyvbjerg A; LeRoith D
Endocrinology; 1995 May; 136(5):1835-42. PubMed ID: 7536658
[TBL] [Abstract][Full Text] [Related]
15. Transient increase in renal insulin-like growth factor binding proteins during initial kidney hypertrophy in experimental diabetes in rats.
Flyvbjerg A; Kessler U; Dorka B; Funk B; Orskov H; Kiess W
Diabetologia; 1992 Jun; 35(6):589-93. PubMed ID: 1377139
[TBL] [Abstract][Full Text] [Related]
16. Octreotide administration in diabetic rats: effects on renal hypertrophy and urinary albumin excretion.
Flyvbjerg A; Marshall SM; Frystyk J; Hansen KW; Harris AG; Orskov H
Kidney Int; 1992 Apr; 41(4):805-12. PubMed ID: 1513103
[TBL] [Abstract][Full Text] [Related]
17. [Octreotide suppresses the kidney weight and glomerular hypertrophy in diabetic rats].
Iwasaki S
Nihon Jinzo Gakkai Shi; 1993 Mar; 35(3):247-55. PubMed ID: 8501854
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor-I (IGF-I) and IGF-I receptor gene expression in the kidney of the chronically hypoinsulinemic rat and hyperinsulinemic rat.
Weiss O; Anner H; Nephesh I; Alayoff A; Bursztyn M; Raz I
Metabolism; 1995 Aug; 44(8):982-6. PubMed ID: 7543652
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor-I and experimental diabetic kidney disease.
Sayed-Ahmed N; Muchaneta-Kubara EC; Besbas N; Shortland J; Cope GH; el Nahas AM
Exp Nephrol; 1993; 1(6):364-71. PubMed ID: 8081988
[TBL] [Abstract][Full Text] [Related]
20. A novel somatostatin analogue prevents early renal complications in the nonobese diabetic mouse.
Landau D; Segev Y; Afargan M; Silbergeld A; Katchko L; Podshyvalov A; Phillip M
Kidney Int; 2001 Aug; 60(2):505-12. PubMed ID: 11473633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
